Skip to content

A Neuroimaging Study of Prolonged Intermittent Theta Burst Stimulation (piTBS) in Subthreshold Depression

Mechanistic Studies of Major Depressive Disorder and the Development of Novel Diagnostic and Therapeutic Strategies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129086
Enrollment
Unknown
Registered
2026-07-30
Start date
2025-06-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Interventions

Intervention Group:Receive piTBS intervention with high frequency and short duration (one session per day over 2 consecutive weeks)
Control Group:Receive sham stimulation under identical conditions

Sponsors

University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18–30 years, of either sex, right-handed, and currently enrolled as a university student; 2.Has a total score of >=14 on the Beck Depression Inventory (BDI) at initial screening; 3.Following assessment by a psychiatrist using the Structured Clinical Interview for DSM-5 Disorders (SCID-5), meets the study-defined operational criteria for subthreshold depression (StD), characterized by the presence of depressive symptoms without meeting the DSM-5 diagnostic criteria for major depressive disorder (MDD) or bipolar disorder; 4.Has at least one core depressive symptom, namely depressed mood or diminished interest or pleasure, persisting for at least 2 weeks; 5. Experiences subjective distress or mild-to-moderate impairment in social functioning; 6. Voluntarily agrees to participate in the study and provides written informed consent.

Exclusion criteria

Exclusion criteria: 1.Meets the DSM-5 diagnostic criteria for major depressive disorder (MDD), bipolar disorder, or any other mental disorder, as determined by the SCID-5 interview; 2. Has a severe medical condition or neurological disorder, such as epilepsy, or a history of traumatic brain injury; 3.Has any contraindication to MRI scanning, such as metallic implants or claustrophobia; 4.Has a history of alcohol or other substance abuse within the past 6 months; 5.Is receiving antidepressant medication or psychotherapy during the intervention period.

Design outcomes

Primary

MeasureTime frame
Total score of the Beck Depression Inventory (BDI);

Secondary

MeasureTime frame
Magnetic resonance imaging characteristic;

Countries

China

Contacts

Public ContactJiao Li

University of Electronic Science and Technology of China

Jiaoli@uestc.edu.cn+86 182 1560 9770

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026